m+Medelevator.RU
← Поиск публикаций
Hemodialysis international. International Symposium on Home Hemodialysis · 2026

The Effect of Education Using the Teach-Back Method on Symptoms of Depression in Hemodialysis Patients.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Acar Elif, Eroglu Semiha Akin, Buyukkilic Busra Zehra, Oren Besey, Cetinkaya Hakki

Аннотация

BACKGROUND: Recently, the Teach-Back Method has gained recognition in the literature as a promising, evidence-based strategy for patient education.

OBJECTIVE: This study aimed to assess the impact of individualized education delivered via the Teach-Back Method on depression levels among adult patients with kidney failure undergoing hemodialysis.

METHODS: A parallel-group trial with a pre-test and post-test design was conducted. The sample comprised 40 hemodialysis patients. Baseline (pre-test) data were collected from all participants. The intervention group received individualized education using the Teach-Back Method, delivered across three sessions. A post-test was administered 12 weeks after the initial assessment.

RESULTS: Pre-test depression scores were comparable between the intervention and control groups (mean = 13.35 and 13.55, respectively), reflecting mild depression. Following the intervention, the mean depression score in the intervention group decreased significantly to 6.20, indicating a reduction below the mild depression threshold. Conversely, the control group's post-test score increased to 16.40, remaining within the mild depression range.

CONCLUSION: These findings suggest that Teach-Back education may reduce depression levels in hemodialysis patients. However, given the small sample size and relatively short follow-up period, larger studies with longer follow-up are needed to confirm these findings.

TRIAL REGISTRATION: NCT07069634.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты